Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Monocle Acquisition Corporation Announces the Separate Trading of Its Common Stock and Warrants Commencing on February 28, 2019
-
MeiraGTx Holdings plc (MGTX) Reports $80 Million Private Placement of Ordinary Shares
-
MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
-
MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
-
Pre-Open Stock Movers 02/25: (ONCE) (CMTA) (QURE) Higher; (MDR) (CRON) (NBR) Lower (more...)
-
Tivity Health (TVTY) PT Raised to $33 at Chardan Capital Markets
-
Chardan Capital Markets Upgrades Audentes Therapeutics (BOLD) to Buy
-
Emergent BioSolutions (EBS) PT Raised to $71 at Chardan Capital Markets
-
Wealthbridge Acquisition Limited Announces Closing of Over-Allotment Option in Connection With Its Initial Public Offering
-
Chardan Capital Markets Starts Kodiak Sciences Inc. (KOD) at Buy; Top Pick for 2019
-
Chardan Capital Markets Downgrades iRhythm Technologies (IRTC) to Neutral
-
Genius Brands Int'l (GNUS) Prices 945.9K Share Registered Direct Offering at $2.12/Sh
-
Genius Brands International Announces $2 Million Registered Direct Offering
-
Form SC 13G/A Chardan Healthcare Acqui Filed by: BOOTHBAY FUND MANAGEMENT, LLC
-
Form SC 13G/A Chardan Healthcare Acqui Filed by: RTW INVESTMENTS, LP
-
Form SC 13G Chardan Healthcare Acqui Filed by: Chardan Investments, LLC
-
Monocle Acquisition Corporation Closes $172.5 Million Initial Public Offering
-
Chardan Capital Markets Starts Wrap Technologies (WRTC) at Buy
-
The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Seventh Annual Cell & Gene Therapy Investor Day
-
The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Seventh Annual Cell & Gene Therapy Investor Day
-
Solid Biosciences (SLDB) PT Lowered to $15 at Chardan Capital Markets
-
UPDATE: Monocle Acquisition Corp. (MNCL) Prices 15M Unit IPO at $10/Unit
-
Monocle Acquisition Corporation Announces Pricing of $150 Million Initial Public Offering
-
Form 10-Q Chardan Healthcare Acqui For: Dec 31
-
Wealthbridge Acquisition Limited (HHHH) Prices 5M Share and Warrant IPO at $10/Unit
-
Wealthbridge Acquisition Limited Announces Pricing of $50 Million Initial Public Offering
-
Chardan Capital Markets Downgrades GenSight Biologics (SIGHT:FP) (GSGTF) to Neutral
-
Chardan Capital Markets Starts Evelo Biosciences Inc (EVLO) at Neutral
-
eHealth (EHTH) PT Raised to $65 at Chardan Capital Markets
-
PlacementTracker Publishes 2018 PIPE and Private Placement Markets League Tables
-
Pre-Open Stock Movers 01/22: (EBAY) (UAA) (PANW) Higher; (ARNC) (PETS) (SWK) Lower (more...)
-
Chardan Capital Markets Upgrades Dicerna Pharmaceuticals (DRNA) to Buy
-
uniQure BV (QURE) Named Top 2019 Pick at Chardan
-
Form 8-K Chardan Healthcare Acqui For: Dec 18
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Gnedy Elliot
-
Form SC 13G Chardan Healthcare Acqui Filed by: RTW INVESTMENTS, LP
-
Form SC 13G Chardan Healthcare Acqui Filed by: BOOTHBAY FUND MANAGEMENT, LLC
-
Form 8-K Chardan Healthcare Acqui For: Dec 18
-
Form 4 Chardan Healthcare Acqui For: Dec 18 Filed by: GROSSMAN JONAS
-
Chardan Healthcare Acquisition Corp. Announces Closing of Initial Public Offering
-
Chardan's Equity Research Team Publishes in a Peer-reviewed Journal
-
Neurotrope (NTRP) Appoints Ivan Gergel MD & Jonathan Schechter to Board
-
Neurotrope Announces the Appointment of Two New Board Members
-
Form 424B4 Chardan Healthcare Acqui
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Rossen Matthew
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: RICE YEHUDA MICHAEL
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Kaufman George
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: GROSSMAN JONAS
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Kusseluk Eric
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Amusa Gbolahan

